PET Radiopharmaceuticals - James R. Ballinger

PET Radiopharmaceuticals

Chemical, Biological, and Clinical Data
Buch | Softcover
XX, 131 Seiten
2022 | 1st ed. 2022
Springer International Publishing (Verlag)
978-3-031-10270-7 (ISBN)
42,79 inkl. MwSt
Jetzt zum Sonderpreis
Listenpreis (bisher): 85,59 €
This book presents in a consistent format data on ~50 PET radiopharmaceuticals in clinical use. Parameters include basic chemical data, normal biodistribution and excretion, activity administered, radiation dosimetry, patient preparation, and clinical utility, together with a few key references.

This book presents in a consistent format data on ~50 PET radiopharmaceuticals in clinical use.  Parameters include basic chemical data, normal biodistribution and excretion, activity administered, radiation dosimetry, patient preparation, and clinical utility, together with a few key references.  In some cases a representative image is presented.  The organisation is first by clinical specialty (oncology, cardiology, neurology) and within each section by radionuclide (F-18, C-11, etc). 

This book will be of interest mostly to nuclear medicine physicians and trainees, but also to a wider medical community including radiologists, oncologists and radiotherapists.



James R Ballinger obtained his BSc in Pharmacy at the University of Toronto, where he later completed a PhD in PET radiochemistry.  He worked as a radiopharmacist and researcher at Ottawa Civic Hospital and Princess Margaret Hospital/Ontario Cancer Institute.  In 1999 he emigrated to the UK where he worked at Addenbrooke’s Hospital in Cambridge and Guy’s & St Thomas’ Hospital in London.  He has held academic cross-appointments at the University of Ottawa, University of Toronto, Cambridge University, and King’s College London. He has written more than 115 peer reviewed research publications, 20 invited review papers, and 18 book chapters.

Chapter 1: Oncology - 18F-labelled agents.- Chapter 2: Oncology - 11C-labelled agents.- Chapter 3: Oncology - 68Ga-labelled agents.- Chapter 4: Oncology - other agents.- Chapter 5: Cardiology - 18F-labelled agents.- Chapter 6: Cardiology - other agents.- Chapter 7: Neurology - 18F-labelled agents.- Chapter 8: Neurology - 11C-labelled agents.- Chapter 9: Neurology - 15O-labelled agents.

Erscheinungsdatum
Reihe/Serie Clinicians’ Guides to Radionuclide Hybrid Imaging
PET/CT
Zusatzinfo XX, 131 p.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 242 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizinische Fachgebiete Radiologie / Bildgebende Verfahren Nuklearmedizin
Medizinische Fachgebiete Radiologie / Bildgebende Verfahren Radiologie
Schlagworte dosimetry • Fluorodeoxyglucose (FDG) • Ga-68 DOTATATE • Ga-68 PSMA • positron emission tomography (PET)
ISBN-10 3-031-10270-3 / 3031102703
ISBN-13 978-3-031-10270-7 / 9783031102707
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Basiswissen und klinische Anwendung

von Markus Dietlein; Klaus Kopka; Matthias Schmidt …

Buch (2023)
Thieme (Verlag)
145,00